Skip to main content
SpringerLink
Log in

The obesity pill, orlistat [Alli], is now licensed to be sold over-the-counter

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. BBC News.The obesity pill, orlistat, has been licensed to be sold over-the-counter at chemists in the EU. Internet Document: [2 pages], 21 Jan 2009. Available from: URL: http://wwwnews.bbc.co.uk

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

The obesity pill, orlistat [Alli], is now licensed to be sold over-the-counter. Pharmacoecon. Outcomes News 571, 11 (2009). https://doi.org/10.2165/00151234-200905710-00027

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905710-00027

Keywords

Search

Navigation